WebELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who: have not responded to or are no longer responding to treatment with platinum-based chemotherapy and. have received 1 to 3 prior types of chemotherapy. WebThe drug labels and other drug-specific information on this Web site represent the most recent drug listing information companies have submitted to the Food and Drug Administration (FDA). (See 21 CFR part 207.) The drug labeling and other information has been reformatted to make it easier to read but its content has neither been altered nor ...
Elahere (mirvetuximab soravtansine) dosing, indications, …
WebNov 15, 2024 · Most patients will receive three to four vials of Elahere per treatment cycle, putting the cost at about $18,500 to $25,000 a cycle, Immunogen Chief Executive Mark Enyedy said on a conference call. WebAdminister ELAHERE as an intravenous infusion only. Prior to administration, ELAHERE must be diluted with 5% Dextrose Injection, USP to a final concentration of 1 mg/mL to 2 mg/mL. Administer the first dose … id_rsa permissions are too open
ImmunoGen gains FDA nod for advanced ovarian cancer drug Elahere
WebNov 15, 2024 · Among 106 patients, the objective response rate on Elahere by investigator assessment was 31.7 percent, including five complete responses. The median duration of response was 6.9 months. ImmunoGen used Roche's assay to select patients who received treatment in the trial. Full approval of Elahere is contingent upon a confirmatory trial. WebNov 15, 2024 · ImmunoGen IMGN announced that the FDA granted accelerated approval for Elahere (mirvetuximab soravtansine-gynx) to treat adults with folate receptor alpha (FRα)-positive, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer, who have received one to three prior systemic treatment regimens.. Elahere is … WebELAHERE Support Services is committed to helping appropriate patients start on ELAHERE by offering access and reimbursement support as well as affordability assistance. For more information, call the ELAHERE Support Services Program at 1-833-ELAHERE (1-833-352-4373) Monday to Friday, 8:00 am to 8:00 pm ET ELAHERE BILLING AND CODING GUIDE is senior match free